📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TRTH-18. COMBINED TOPOTECAN AND CARBOPLATIN THERAPY FOR DIPG SUPPRESSES CELL GROWTH IN VITRO AND IS WELL TOLERATED WHEN DELIVERED BY CONVECTION ENHANCED DELIVERY IN VIVO (2017)

First Author: Bienemann A

Attributed to: Malignant Glioma immunotherapy by histone deacetylase inhibition administered by convection enhanced delivery. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/nox083.229

Publication URI: http://dx.doi.org/10.1093/neuonc/nox083.229

Type: Journal Article/Review

Parent Publication: Neuro-Oncology

Issue: suppl_4